{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:26:09Z","timestamp":1764174369444},"reference-count":51,"publisher":"Consilium Medicum","issue":"5","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To determine risk factors for severe cardiovascular (CV) events (CVEs) in male patients with crystal-verified gout. Subjects and methods. 251 male patients with crystal-verified gout were prospectively followed up in 2003 to 2013. The mean follow-up period was 6.9\u00b12.0 years. New severe CVE cases and deaths were recorded. Logistic regression was used to analyze the impact of traditional and other risk factors and allopurinol use on the risk for severe CVEs. Results. 32 patients died during the follow-up period. Severe CVEs were recorded in 58 (23.1%) patients; CVE deaths were notified in 22 (8.8%) patients. The risk of all severe CVEs was high for hypertension, increased serum high-sensitivity C-reactive protein (hs-CRP) level (&gt;5 mg\/l), \u2265 stage III chronic kidney disease (CKD) (glomerular filtration rate, 20 g\/day), coronary heart disease (CHD), and a family history of premature CHD. The risk of fatal CVEs was highest for elevated serum hs-CRP level, \u2265stage III CKD, a family history of premature CHD, hypercholesterolemia, upper quartile of serum uric acid levels (&gt;552 \u00b5mol\/l), and regular intake of allopurinol. Conclusion. In addition to the traditional risk factors of CV catastrophes, the presence of chronic inflammation and the impact of high serum uric acid levels may explain the high frequency of CV catastrophes.<\/jats:p>","DOI":"10.17116\/terarkh201789510-19","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T16:38:04Z","timestamp":1497631084000},"page":"10-19","source":"Crossref","is-referenced-by-count":15,"title":["Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study"],"prefix":"10.26442","volume":"89","author":[{"given":"M S","family":"Eliseev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I S","family":"Denisov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E I","family":"Markelova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S I","family":"Glukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E L","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3199"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.30520"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894-900.","DOI":"10.1161\/CIRCULATIONAHA.107.703389"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.10.1104"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep364"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202421"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes169"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket293"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000282"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121061"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/ar3684"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke. 2003;34(8):1951-196.","DOI":"10.1161\/01.STR.0000081983.34771.D2"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros VG. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71(7):1120-1127.","DOI":"10.1253\/circj.71.1120"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.198"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006; 54(8):2688-2696.","DOI":"10.1002\/art.22014"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2376-2"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Pascual E. Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum. 1991;34(2):141-145.","DOI":"10.1002\/art.1780340203"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006;116(8):2262-2271.","DOI":"10.1172\/JCI28075"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu218"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25(6):1102-1111.","DOI":"10.1161\/01.ATV.0000163262.83456.6d"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.050"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract. 2005;59(11):1276-1282.","DOI":"10.1111\/j.1742-1241.2005.00621.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.07.080"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/art.33369"},{"key":"ref26","unstructured":"International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Volume 1-3. Russian edition. Medicine. The World Health Organization, Geneva. 1995."},{"key":"ref27","unstructured":"World Health Organization: International Statistical Classification of Diseases and Related Health Problems 10th Revision, Version for 2010. Geneva: World Health Organization. Accessed Jun 2011. http:\/\/apps.who.int\/classifications\/ apps\/isd\/isd\/10online\/"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.01.007"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct083"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/2047487313514895"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.143"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/ar3322"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Sundstr\u00f6m J, Sullivan L, D\u2019Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28-33.","DOI":"10.1161\/01.HYP.0000150784.92944.9a"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR, Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48(6):1037-1042.","DOI":"10.1161\/01.HYP.0000249768.26560.66"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Tavil Y, Kaya MG, Oktar SO, Sen N, Okyay K, Yazici HU, Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008; 197(1):159-163.","DOI":"10.1016\/j.atherosclerosis.2007.03.008"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med. 2005;2(3):e76.","DOI":"10.1371\/journal.pmed.0020076"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis. 2007;17(6):409-414.","DOI":"10.1016\/j.numecd.2007.02.011"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9322-2"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114(23):2508-2516.","DOI":"10.1161\/CIRCULATIONAHA.106.651117"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03887.x"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03953"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205269"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61717-7"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr310"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113696"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2644-9"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/ar3223"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154997"},{"key":"ref50","unstructured":"Chowalloor P, Cheah P, Keen HI. Subclinical Synovial Inflammation in Gout. Arthritis & Rheumatology. ACR 2014;66(11)(Suppl.):S64."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945b79"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32176\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:39:53Z","timestamp":1634078393000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/32176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.17116\/terarkh201789510-19","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}